Press Releases

T2 Biosystems, Inc, a leader in the rapid detection of sepsis-causing pathogens, announced that its T2SARS-CoV-2™ Panel detects Omicron COVID-19 subvariants BA.1, BA.2, and BA.3. According to the Centers for Disease Control and Prevention, the Omicron variant of the SARS-CoV-2...

Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced a new capacity expansion plan in the United States and Colombia for its Funtrition business through a new gummy manufacturing facility and increased manufacturing capabilities to meet rising...

Castor, a leading provider of decentralized and hybrid clinical trial solutions, announced the official launch of its CRO Partnership program. Designed to support clinical research organizations (CROs), the program provides the technical capabilities, operational training and commercial resources required...

Gerresheimer is expanding its capacities for glass vials at the Wertheim site and at two further sites in China and the USA. The company is investing in production in Wertheim to increase vials capacity by 150 million vials per...

Cytiva, a global life sciences leader, and NecstGen, aim to accelerate the development of new cell and gene therapies globally via a strategic collaboration. Cytiva will provide its technologies, services, and solutions to NecstGen, and both organizations will share...

Valneva SE, a specialty vaccine company, announced the initiation of a Phase 3 trial in adolescents for its single-shot chikungunya vaccine candidate, VLA1553. Funded by the Coalition for Epidemic Preparedness Innovations (CEPI), the trial is intended to support the label...

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that the Russian Sputnik V vaccine against coronavirus has been granted full permanent approval by Russia’s Health Ministry. It had previously held temporary emergency use authorization (EUA) from...